Albuquerque, New Mexico
Velocity Clinical Research, Albuquerque
Velocity's research site in Albuquerque was founded in 2017 as the fourth site of MedPharmics and acquired by Velocity in 2022. Since its inception, the site has conducted trials in Infectious Diseases and Women’s Health, including over 15 vaccine trials. Our Albuquerque site played an integral role during the height of the COVID-19 pandemic, conducting COVID-19 trials for both children and adults.
The site is easily accessible. Additionally, half of the clinic staff is bilingual and can comfortably accommodate Spanish speaking patients. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Albuquerque team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.
Velocity Clinical Research, Albuquerque
3901 Carlisle Blvd NE, Albuquerque, NM 87107
Phone: (505) 243-1627
Find a Clinical Trial in Albuquerque
Sign up below to speak with an enrollment specialist about available research studies in Albuquerque.
Follow Velocity on Facebook for company updates and more.
Our experienced research team in Albuquerque
Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Albuquerque is dedicated to conducting quality research in a professional and caring environment.
Sara Friedman, MD attended Brandeis University where she earned her undergraduate degree in Biology. Following her stint in Massachusetts, Dr. Friedman spent time working in clinical research as a research assistant before attending the University of New Mexico School of Medicine. She then completed her OBGYN residency at the University of California, Davis in 2009 before returning to Albuquerque to work in a private practice. Dr. Friedman spent time with three groups until 2020, when she returned to clinical research in a full-time role as a principal investigator. Through her efforts in clinical research, Dr. Friedman hopes to make an impact by bringing new treatments and technologies to the Albuquerque community and more.
Quito Osuna Carr, MD joined the clinical trial industry as a principal investigator in 2018. With his 50 years of experience as a physician, he has provided invaluable insight in trials in various therapeutic areas. Although semi-retired, he continues to help the Velocity Albuquerque site in an investigator role. He began his career in various clinics across California before returning to New Mexico. While in New Mexico, Dr. Carr ran his practice for 18 years and worked as an emergency physician for 17 years. Dr. Carr earned his medical degree from Stanford School of Medicine after receiving his undergraduate degree from University of New Mexico. Additionally, Dr. Carr completed his HEW fellowship of tropical medicine in Brazil, Uganda, and Sri Lanka.
Complete the form to start your clinical trial journey in Albuquerque
Why join a clinical trial?
- Help advance medicine
- Learn about potential new medicines in development
- Receive study-related medical exams at no cost
- Compensation for participating may be available (amounts my differ for each study)
After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.
Health insurance is generally not needed to join a clinical trial.
Remember, there is never an obligation to join — we're here to help you make the best decision.
Submit your info
Sponsors and CROs
From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.